The Medicines Company (NASDAQ: MDCO) today announced that investigators will present new analyses from high-risk percutaneous coronary intervention (PCI) patient ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE